A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Clinical trial NCT05319353 · RECRUITING
Trial details
- NCT number
- NCT05319353
- Sponsor
- Takeda
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-13
- Primary completion
- 2027-01-18
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.